Pharmaniaga to supply, distribute 200,000 doses of Sinovac Covid-19 vaccine

Updated 2 years ago · Published on 22 Mar 2021 5:15PM · 0 Comments

Pharmaniaga Lifescience Sdn Bhd will supply and distribute 200,000 doses of the imported finished product of Covid-19 vaccine developed and manufactured by Sinovac Life Sciences Co Ltd. – EPA pic, March 22, 2021.

PHARMANIAGA Bhd’s wholly owned subsidiary, Pharmaniaga Lifescience Sdn Bhd, has signed an agreement with the government through the Health Ministry to supply and distribute 200,000 doses of the imported finished product of Covid-19 vaccine by Sinovac.

The vaccine has been developed and manufactured by Sinovac Life Sciences Co Ltd, a subsidiary of Sinovac Biotech Ltd.

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!

Sign up or sign in here to comment.

Comments